HEMATOPOIESIS AND STEM CELLS Mef2C is a lineage-restricted target of Scl/Tal1 and regulates megakaryopoiesis and B-cell homeostasis

1Department of Molecular, Cell and Developmental Biology, University of California–Los Angeles; 2Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; 3Department of Biologic Chemistry, University of California–Los Angeles; 4Department of Pathology and Laboratory Medicine, University of California–Los Angeles; 5Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas; 6Division of Hematology/Oncology, Children’s Hospital Boston, Harvard Medical School, MA; 7Howard Hughes Medical Institute, Boston, MA; 8Harvard Stem Cell Institute, Boston, MA; 9Molecular Biology Institute, University of California–Los Angeles; 10Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at University of California–Los Angeles; and 11Jonsson Comprehensive Cancer Center, University of California–Los Angeles